NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Novo Nordisk A/S (CO: NOVO-B)

 
NOVO-B Technical Analysis
5
As on 19th Feb 2026 NOVO-B STOCK Price closed @ 307.40 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 479.44 & Strong Sell for SHORT-TERM with Stoploss of 652.91 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

NOVO-BSTOCK Price

Open 312.10 Change Price %
High 313.15 1 Day -3.90 -1.25
Low 305.85 1 Week -7.55 -2.40
Close 307.40 1 Month -62.95 -17.00
Volume 4137800 1 Year -440.20 -58.88
52 Week High 790.30 | 52 Week Low 280.65
 
CO Denmark Most Active Stocks
SAS 0.01 0.00%
NOVO-B 307.40 -1.25%
CONFRZ 0.02 0.00%
VWS 159.75 0.98%
VJBA 7.33 0.41%
ORSTED 152.40 -1.04%
SHAPE 5.03 30.65%
ISS 244.00 -3.71%
ALMB 16.63 -0.42%
GREENH 0.41 -6.82%
 
CO Denmark Top Gainers Stocks
HYDRCT 0.60 46.34%
SHAPE 5.03 30.65%
HYPE 3.66 22.00%
DKIEEU 249.00 15.81%
CBRAIN 80.70 10.70%
SAME 1.45 10.69%
SAME 1.45 10.69%
ASTRLS 1.15 8.49%
DFDS 101.90 6.15%
MAPS 0.37 5.71%
 
CO Denmark Top Losers Stocks
VALUER 0.25 -21.88%
BLVIS-A 0.40 -18.37%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
 
 
NOVO-B
Daily Charts
NOVO-B
Intraday Charts
Whats New @
Bazaartrend
NOVO-B
Free Analysis
 
NOVO-B Important Levels Intraday
RESISTANCE321.47
RESISTANCE316.96
RESISTANCE314.17
RESISTANCE311.38
SUPPORT303.42
SUPPORT300.63
SUPPORT297.84
SUPPORT293.33
 
NOVO-B Forecast February 2026
4th UP Forecast524.96
3rd UP Forecast455.19
2nd UP Forecast412.06
1st UP Forecast368.93
1st DOWN Forecast245.87
2nd DOWN Forecast202.74
3rd DOWN Forecast159.61
4th DOWN Forecast89.84
 
NOVO-B Weekly Forecast
4th UP Forecast415.50
3rd UP Forecast380.83
2nd UP Forecast359.40
1st UP Forecast337.97
1st DOWN Forecast276.83
2nd DOWN Forecast255.40
3rd DOWN Forecast233.97
4th DOWN Forecast199.30
 
NOVO-B Forecast2026
4th UP Forecast1331.02
3rd UP Forecast1002.74
2nd UP Forecast799.82
1st UP Forecast596.9
1st DOWN Forecast17.9
2nd DOWN Forecast-185.02
3rd DOWN Forecast-387.94
4th DOWN Forecast-716.22
 
 
NOVO-B Other Details
Segment EQ
Market Capital 1565371138048.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
NOVO-B Address
NOVO-B
 
NOVO-B Latest News
 
Your Comments and Response on Novo Nordisk A/S
 
NOVO-B Business Profile
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Lund University to develop treatment for Parkinson's diseases; and bluebird bio, Inc. to develop genome editing treatments for children and adult patients. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark. Address: Novo Allé 1, Bagsvaerd, Denmark, 2880
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service